- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07568717
Healing Together: Partners' Experiences in the Journey of Sexual Trauma Recovery Through the Intervention Take Your Sexuality Back for Sexually Traumatized Women.
April 28, 2026 updated by: Idun Røseth, Sykehuset Telemark
Take Your Sexuality Back - a Feasibility Study of a New Intervention for Sexually Traumatized Women
This study aims to gain insight into the experiences of partners to participants in the "Take Your Sexuality Back" intervention groups, evaluate the intervention's acceptability, and identify necessary modifications.
This study is part of a larger project that seeks to establish a scientific basis for this innovative, group-based treatment to help women who have experienced sexual trauma heal their sexuality.
Before implementing the intervention in the healthcare system and initiating a larger randomized controlled trial, the investigators will evaluate the intervention's feasibility and potential efficacy, as well as gain a more comprehensive understanding of treatment outcomes.
In addition to collecting quantitative data, it is crucial to gather qualitative data on participants' and participants partners´ experiences.
In this study, data will be obtained through in-depth interviews with partners´ to group participants after they complete the intervention.
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Telemark
-
Skien, Telemark, Norway, 3710
- Telemark Hospital Trust
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Being partner of a participant in the intervention group.
Exclusion Criteria:
- Living in an abusive relationship with the participant in the intervention group
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treatment group "Take your sexuality back"
"Take your sexuality back" is a 12 week group intervention for sexually traumatized women.
|
The intervention is trauma-sensitive and focus both on traumatized sexuality and positive sexuality.
It incorporates regulatory skills to prevent re-traumatization when addressing sex-positive themes, thus accommodating a wide range of trauma-related symptoms, sexual shame, sexual dysfunctions, and regulation difficulties.
The intervention integrates psychoeducation, exercises, reflections and sharing.
The intervention include partners to participants in two of the sessions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
What are the partners' experiences of participating in the intervention and of being witness to and taking part in their partners (participants) process during the intervention?
Time Frame: 1-2 weeks after participants have completed the intervention.
|
In-depth interviews investigating partners´ experiences and perspectives of the intervention groups, with the aim of identifying areas for potential improvement in the intervention and specifically how partners can best be involved in the rehabilitation process.
Interviews will be analyzed through a descriptive phenomenological method.
|
1-2 weeks after participants have completed the intervention.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Hege Kersten, PhD, Sykehuset Telemark
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 27, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
December 1, 2028
Study Registration Dates
First Submitted
April 28, 2026
First Submitted That Met QC Criteria
April 28, 2026
First Posted (Actual)
May 6, 2026
Study Record Updates
Last Update Posted (Actual)
May 6, 2026
Last Update Submitted That Met QC Criteria
April 28, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REKNR829297
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Qualitative data are sensitive and participant anonymity cannot be guaranteed.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.